This is another victory for Pfizer, and a double winner after the unprecedented success of its vaccine developed with BioNTech.
Its anti-Covid tablet, Paxlovid, has just been approved by the Food & Drug Administration, the US health authority.
One more tool in the arsenal against the pandemic and the Omicron surge.
Read also
Merck's anti-Covid pill authorized in the United States
"The authorization granted to Paxlovid is a great new example of how science will help us beat this pandemic"
Albert Bourla, CEO of Pfizer
And this, while two drugs used so far, those from Regeneron and Lilly, have been shown to be ineffective against the new variant.
"
The authorization granted to Paxlovid represents a great new example of how science will help us overcome this pandemic which, two years after its onset, continues to disrupt and destroy lives around the world,
" said Albert Bourla, CEO of Pfizer.
This five-day treatment, administered in the very first moments after a positive diagnosis, has been shown to be 90% effective against the risks of hospitalization and death in people at risk.
It must be combined with another antiviral ...
This article is for subscribers only.
You have 76% left to discover.
To cultivate one's freedom is to cultivate one's curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
